Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Suspended Phase 2 Interventional

Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma

ClinicalTrials.gov ID: NCT06179888

Public ClinicalTrials.gov record NCT06179888. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 6:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multiple Myeloma Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This phase II trial compares iberdomide maintenance therapy to disease monitoring for improving survival in patients who have received idecabtagene vicleucel (a type of chimeric antigen receptor T-cell \[CAR-T\] therapy) for multiple myeloma. The usual approach after treatment with idecabtagene vicleucel is to monitor the multiple myeloma without giving myeloma medications. There is currently no medication approved specifically for use after idecabtagene vicleucel treatment. Upon administration, iberdomide modifies the immune system and activates immune cells called T-cells, which could enhance the effectiveness of idecabtagene vicleucel. Iberdomide may keep multiple myeloma under control for longer than the usual approach (disease monitoring) after idecabtagene vicleucel, and may help multiple myeloma patients live longer.

Study identification

NCT ID
NCT06179888
Recruitment status
Suspended
Study type
Interventional
Phase
Phase 2
Enrollment
84 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 27, 2024 (Actual)
Primary completion
Mar 1, 2030 (Estimated)
Completion
Mar 1, 2030 (Estimated)
Last update posted
Oct 19, 2026

2024 – 2030

United States locations

U.S. sites
74
U.S. states
20
U.S. cities
58
Facility City State ZIP Site status
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine California 92612 —
Cedars-Sinai Medical Center Los Angeles California 90048 —
UC Irvine Health/Chao Family Comprehensive Cancer Center Orange California 92868 —
University of California Davis Comprehensive Cancer Center Sacramento California 95817 —
Augusta University Medical Center Augusta Georgia 30912 —
University of Illinois Chicago Illinois 60612 —
UI Health Care Mission Cancer and Blood - Ankeny Clinic Ankeny Iowa 50023 —
UI Health Care Mission Cancer and Blood - West Des Moines Clinic Clive Iowa 50325 —
Iowa Methodist Medical Center Des Moines Iowa 50309 —
UI Health Care Mission Cancer and Blood - Des Moines Clinic Des Moines Iowa 50309 —
Mercy Medical Center - Des Moines Des Moines Iowa 50314 —
UI Health Care Mission Cancer and Blood - Laurel Clinic Des Moines Iowa 50314 —
UI Health Care Mission Cancer and Blood - Waukee Clinic Waukee Iowa 50263 —
Baptist Memorial Hospital and Cancer Center-Desoto Southhaven Mississippi 38671 —
Siteman Cancer Center at Saint Peters Hospital City of Saint Peters Missouri 63376 —
Siteman Cancer Center at West County Hospital Creve Coeur Missouri 63141 —
Washington University School of Medicine St Louis Missouri 63110 —
Siteman Cancer Center-South County St Louis Missouri 63129 —
Siteman Cancer Center at Christian Hospital St Louis Missouri 63136 —
Nebraska Medicine-Bellevue Bellevue Nebraska 68123 —
Nebraska Medicine-Village Pointe Omaha Nebraska 68118 —
University of Nebraska Medical Center Omaha Nebraska 68198 —
Memorial Sloan Kettering Monmouth Middletown New Jersey 07748 —
Memorial Sloan Kettering Bergen Montvale New Jersey 07645 —
Memorial Sloan Kettering Commack Commack New York 11725 —
Memorial Sloan Kettering Westchester Harrison New York 10604 —
Memorial Sloan Kettering Cancer Center New York New York 10065 —
UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 —
Carolinas Medical Center/Levine Cancer Institute Charlotte North Carolina 28203 —
Atrium Health Pineville/LCI-Pineville Charlotte North Carolina 28210 —
Atrium Health University City/LCI-University Charlotte North Carolina 28262 —
Atrium Health Cabarrus/LCI-Concord Concord North Carolina 28025 —
Levine Cancer Institute - Huntersville Huntersville North Carolina 28078 —
Atrium Health Union/LCI-Union Monroe North Carolina 28112 —
Wake Forest University Health Sciences Winston-Salem North Carolina 27157 —
Sanford Broadway Medical Center Fargo North Dakota 58122 —
Sanford Roger Maris Cancer Center Fargo North Dakota 58122 —
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 —
Providence Portland Medical Center Portland Oregon 97213 —
Providence Saint Vincent Medical Center Portland Oregon 97225 —
Geisinger Medical Center Danville Pennsylvania 17822 —
Prisma Health Cancer Institute - Eastside Greenville South Carolina 29615 —
Baptist Memorial Hospital and Cancer Center-Memphis Memphis Tennessee 38120 —
Houston Methodist San Jacinto Hospital Baytown Texas 77521 —
Houston Methodist Cypress Hospital Cypress Texas 77429 —
Houston Methodist Hospital Houston Texas 77030 —
Methodist Willowbrook Hospital Houston Texas 77070 —
Houston Methodist West Hospital Houston Texas 77094 —
Houston Methodist Saint John Hospital Nassau Bay Texas 77058 —
Houston Methodist Sugar Land Hospital Sugar Land Texas 77479 —
Houston Methodist The Woodlands Hospital The Woodlands Texas 77385 —
University of Vermont Medical Center Burlington Vermont 05401 —
University of Vermont and State Agricultural College Burlington Vermont 05405 —
Swedish Cancer Institute-Edmonds Edmonds Washington 98026 —
Swedish Cancer Institute-Issaquah Issaquah Washington 98029 —
Fred Hutchinson Cancer Center Seattle Washington 98109 —
Swedish Medical Center-First Hill Seattle Washington 98122 —
Aurora Cancer Care-Southern Lakes VLCC Burlington Wisconsin 53105 —
Aurora Saint Luke's South Shore Cudahy Wisconsin 53110 —
Aurora Health Care Germantown Health Center Germantown Wisconsin 53022 —
Aurora Cancer Care-Grafton Grafton Wisconsin 53024 —
Aurora BayCare Medical Center Green Bay Wisconsin 54311 —
Aurora Cancer Care-Kenosha South Kenosha Wisconsin 53142 —
Aurora Bay Area Medical Group-Marinette Marinette Wisconsin 54143 —
Aurora Cancer Care-Milwaukee Milwaukee Wisconsin 53209 —
Aurora Saint Luke's Medical Center Milwaukee Wisconsin 53215 —
Aurora Sinai Medical Center Milwaukee Wisconsin 53233 —
Vince Lombardi Cancer Clinic - Oshkosh Oshkosh Wisconsin 54904 —
Aurora Cancer Care-Racine Racine Wisconsin 53406 —
Vince Lombardi Cancer Clinic-Sheboygan Sheboygan Wisconsin 53081 —
Aurora Medical Center in Summit Summit Wisconsin 53066 —
Vince Lombardi Cancer Clinic-Two Rivers Two Rivers Wisconsin 54241 —
Aurora Cancer Care-Milwaukee West Wauwatosa Wisconsin 53226 —
Aurora West Allis Medical Center West Allis Wisconsin 53227 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06179888, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 19, 2026 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06179888 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →